INTRODUCTION
Pseudoaneurysm of mitral-aortic intervalvular fibrosa (P-MAIVF) is a rare but potentially lethal complication of aortic valve endocarditis, especially with prosthetic aortic valves. 1 Early surgery is generally recommended in these patients because of risk of possible fatal complications. 2, 3 There are very few cases reported in literature wherein patients with P-MAIVF have been managed conservatively for years after initial diagnosis. 4, 5 We report a case of large P-MAIVF in a patient who was treated for infective endocarditis of a native aortic valve, and was managed conservatively for 3 years with an uncomplicated course,and a small increase in the size of the pseudoaneurysm.
CASE REPORT
An eleven years old boy presented to us with a history of high grade fever for 28 days and sudden onset weakness of left side of the body for 4 days. He had received intravenous ceftriaxone for 1 week prior to admission from a private practitioner outside the hospital. On general examination he was conscious and oriented to time, place and person. His temperature was 104 o F, pulse rate was 120 beats per minute, blood pressure was 110/60 mm Hg and respiratory rate was 18 per minute. He had pallor and grade 2 clubbing. Cardiovascular examination revealed a carotid thrill, hyperdynamic precordium, Grade IV ejection systolic murmur and an early diastolic murmur at the aortic area. There were no signs of heart failure. Neurological examination showed left sided hemiparesis with grade 2/5 power in both left upper and lower limbs, brisk deep tendon reflexes on left side, an extensor left plantar response and left upper motor neuron type facial palsy. Chest and abdominal examination was unremarkable. Haemogram revealed normocytic normochromic anemia with hemoglobin -9.5 gm/dl, total leucocyte count -13,500/ ml, differential counts -75% neutophils, 20% lymphocytes and 8% monocytes, and platelet counts -2,54,000/ml. ESR was 45 mm/hour. Blood urea, serum creatinine, liver function tests, arterial blood gases, serum electrolytes, urine examination, chest X-ray and USG abdomen were normal. Blood culture was sterile thrice, as was urine culture. ECG showed sinus tachycardia. CT head was suggestive of an ischemic infarct in the right MCA territory which was confirmed on MRI brain. A transthoracic echocardiogram (TTE) was performed and revealed a bicuspid aortic valve with severe aortic stenosis (mean gradient-45 mmHg, aortic valve area-0.6 cm 2 /m 2 ), moderate aortic regurgitation and vegetations attached to the ventricular surface of non-coronary cusp. Patient was managed with intravenous ceftriaxone and vancomycin for 6 weeks and showed signs of clinical recovery with mild residual hemiparesis. A predischarge TTE was performed that revealed a pulsatile outpouching arising from the left ventricular outflow tract, just beneath the aortic annulus, in the region of mitral-aortic intervalvular fibrosa ( Figure 1 ). Its diastolic dimensions were 1.8 × 2.4 cm. Color flow Doppler examination demonstrated that the lesion was freely communicating with the left ventricular outflow tract (LVOT) and showed typical systolic expansion and diastolic collapse (Video 1). Patient was further investigated with transesophageal echocardiography (TEE), and cardiac MRI which confirmed the diagnosis of bicuspid aortic valve disease with a large (diastolic dimensions-1.8 × 2.5 × 2.9 cm) P-MAIVF related anteriorly to the aortic root and posteriorly to left atrium ( Figure 2 ). Ascending aorta was dilated and measured 3.6 × 3.5 cm. There were no signs of rupture of the pseudoaneurysm into left atrium, ascending aorta or pericardial cavity. The case was discussed in a forum consisting of senior cardiologists and cardiac surgeons and it was decided that the patient should undergo an early surgical treatment. However patient's parents refused surgery and he was managed conservatively for a period of 3 years with periodic echocardiographic assessment of aortic valve, left ventricular size and functions, pseudoaneurysm size and development of any complications. The need of surgical treatment was also reemphasized to the patient's parents at each visit. At the end of 3 years patient had minimal cardiac symptoms, aortic regurgitation had become severe, left ventricular dimensions had progressively increased and pseudoaneurysm had mildly but definitely increased in size (diastolic dimensions-2.0 × 2.7 cm on TTE). Ascending aortic size had also increased (3.9 × 3.8 cm). This time, patient's parents accepted surgery and he was referred for aortic valve replacement and reconstruction of MAIVF.
DISCUSSION
Mitral-aortic intervalvular fibrosa (MAIVF) is a thin, translucent membranous structure joining the left half of noncoronary cusp and adjacent third of left coronary cusp of the aortic valve and the anterior mitral leaflet. 6 Its anterior edge is contiguous with the left fibrous trigone and posterior edge is contiguous with the right fibrous trigone. It is bound posterolaterally by the left atrium, superiorly by the pericardium and inferiorly by the left ventricular outflow tract. 7 It is of great clinical and surgical importance as it is responsible for maintaining the structural and functional integrity of both mitral and aortic valves. 6 Pseudoaneurysm of MAIVF (P-MAIVF) most commonly occurs as a complication of aortic valve endocarditis, particularly with prosthetic aortic valves. 1 It can also be associated with chest trauma, cardiac surgery, tuberculosis and Takayasu arteritis. [8] [9] [10] [11] Some cases are believed to be of congenital origin. 12 Being a fragile and sparsely vascularized structure, it offers little resistance to infection and is thus prone to develop abscess or pseudoaneurysm. 13 Clinically, patients with P-MAIVF may be asymptomatic, present with features of infective endocarditis or complications. Complications of P-MAIVF include rupture into left atrium leading to supra-annular mitral regurgitation an consequent acute heart failure, rupture into pericardial cavity causing cardiac tamponade, systolic compression of left coronary artery causing angina, rupture towards chest wall producing fistula, stroke due to thromboembolismand sudden death. [13] [14] [15] [16] [17] Echocardiography is the primary imaging modality for the diagnosis of P-MAIVF. Transesophageal echocardiography (TEE) is superior to transthoracic echocardiography (TTE) for diagnosing P-MAIVF. Afridi I et al reported that diagnositic sensitivity of TTE to detect P-MAIVF is 43% which may increase to 90% when TEE is utilized. 2 On echocardiography, P-MAIVF appears as a pulsatile outpouching located between the aortic root and the anterior mitral leaflet. 2 Its most characteristic echocardiographic fea-ture is marked pulsatility with systolic expansion and diastolic collapse which indicates its direct communication with the left ventricular cavity. Color flow Doppler demonstrates free flow of blood from left ventricular cavity into P-MAIVF and also detects rupture of P-MAIVF into the left atrium or aorta. 2 Differential diagnosis of P-MAIVF includes aortic ring abscess, aorto-left ventricular tunnel and aneurysm of sinus of Valsalva. It may be particularly difficult to differentiate small P-MAIVF from an aortic ring abscess on echocardiography. In general ring abscesses are small, nonpulsatile and show either no flow or continuous systolic and diastolic flow. 2 Real time 3D echocardiography has also been used for providing useful anatomical insight regarding location of P-MAIVF and its relationship with the adjacent structures. 18 Recently, ECG gated multidetector CT and cardiac MRI have been utilized for detailed 3D anatomical reconstruction and dynamic evaluation of P-MAIVF with high spatial and temporal resolution. 19 Natural history of P-MAIVF is unclear. Surgery is generally recommended, even in asymptomatic patients, because of risk of possible fatal complications.
2 Surgical treatment includes resection of P-MAIVF and reconstruction of MAIVF with or without aortic valve, mitral valve or homograft aortic root replacement. 16 Coronary artery bypass grafting may be necessary when there is coronary involvement. 13 Surgery of P-MAIVF is technically demanding and associated with high risk of mortality and morbidity. De Oliveira et al reported an operative mortality of 10%, late mortality of 24% and 10 year survival of 50% in 76 patients undergoing reconstruction of MAIVF with aortic and mitral valve replacement. 20 Additionally, successful percutaneous device closure of P-MAIVF has also been reported. 7 Till date, there are very few cases reported in literature wherein patients with P-MAIVF have been managed conservatively for years after initial diagnosis. 4, 5 In most of these cases, the pseudoaneurysms were small and not associated with any complications. In our case, the P-MAIVF was large, although unruptured and not causing any significant compression of surrounding vital structures. It had become only slightly larger after three years and was not causing any symptoms, although due to severe aortic regurgitation the left ventricle and aorta had progressively dilated. This increase in size could be attributed to the persistent blood flow in and out of the pseudoaneurysm over a period of time. Patient was ultimately referred for surgery (Aortic valve replacement and reconstruction of MAIVF). In summary, our case underscores the role of routine pre-discharge echocardiography in detecting the sub-valvular complications of aortic valve endocarditis, and also demonstrates that close clinical follow up and periodic imaging may be a reasonable alternative to early surgery in managing patients with uncomplicated P-MAIVF. Further research is needed to establish whether this nonsurgical strategy should be recommended for the management of such patients.
CONCLUSION
Pesudoaneurysm of mitral-aortic intervalvular fibrosa is a rare but dreaded complication of aortic valve endocarditis. Although early surgery is the treatment of choice, expectant management with close clinical follow up and serial imaging may be a reasonable alternative strategy of managing patients with uncomplicated P-MAIVF. Further studies are needed to establish whether this approach should be recommended for the management of such patients.
